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Abstract
Background: Canonical WNT signalling plays a critical role in the regulation of ovarian development; mis-regulation
of this key pathway in the adult ovary is associated with subfertility and tumourigenesis. The roles of Adenomatous
polyposis coli 2 (APC2), a little-studied WNT signalling pathway regulator, in ovarian homeostasis, fertility and
tumourigenesis have not previously been explored. Here, we demonstrate essential roles of APC2 in regulating
ovarian WNT signalling and ovarian homeostasis.
Methods: A detailed analysis of ovarian histology, gene expression, ovulation and hormone levels was carried out
in 10 week old and in aged constitutive APC2-knockout (Apc2−/−) mice (mixed background). Statistical significance
for qRT-PCR data was determined from 95% confidence intervals. Significance testing was performed using 2-tailed
Student’s t-test, when 2 experimental cohorts were compared. When more were compared, ANOVA test was used,
followed by a post-hoc test (LSD or Games-Howell). P-values of < 0.05 were considered statistically significant.
Results: APC2-deficiency resulted in activation of ovarian WNT signalling and sub-fertility driven by intra-ovarian
defects. Follicular growth was perturbed, resulting in a reduced rate of ovulation and corpora lutea formation,
which could not be rescued by administration of gonadotrophins. Defects in steroidogenesis and follicular
vascularity contributed to the subfertility phenotype. Tumour incidence was assessed in aged APC2-deficient mice,
which also carried a hypomorphic Apc allele. APC2-deficiency in these mice resulted in predisposition to granulosa
cell tumour (GCT) formation, accompanied by acute tumour-associated WNT-signalling activation and a histologic
pattern and molecular signature seen in human adult GCTs.
Conclusions: Our work adds APC2 to the growing list of WNT-signalling members that regulate ovarian
homeostasis, fertility and suppress GCT formation. Importantly, given that the APC2-deficient mouse develops
tumours that recapitulate the molecular signature and histological features of human adult GCTs, this mouse has
excellent potential as a pre-clinical model to study ovarian subfertility and transitioning to GCT, tumour biology and
for therapeutic testing.
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Background
The canonical WNT signalling pathway is central to nu-
merous biological processes and diseases [1]. Within the
ovary, the pathway has been shown to be essential for fe-
male sex differentiation during embryogenesis [2–9],
however, in the adult ovary its role is less well defined.
Conditional deletion of β-catenin within murine granu-
losa cells of antral follicles did not affect folliculogenesis
or ovulation [10, 11], but its removal within oviducts
and uteri led to abnormalities therein, with lack of im-
plantation sites rendering mice infertile as a result [11].
Conditional deletion of Wnt4 in ovarian granulosa cells
or germline deletion of Fzd4 in mice caused sub-fertility
or complete infertility respectively [12, 13], but WNT
signalling activity was not measured and it is unclear
whether the reported phenotypes were caused by im-
paired ovarian canonical WNT signalling or by other
mechanisms, potentially including non-canonical path-
ways. In mice with germline deletion of the WNT signal-
ling agonist Fzd1,
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17.6% of female mice were infertile and characterized
by early follicle depletion, but with no concomitant
change in total activated β-catenin levels [14]. Over-
activation of canonical WNT signalling also has deleteri-
ous effects on ovarian homeostasis. Ovarian amplifica-
tion of Rspo1 [15], deletion of Wnt5a (antagonist of
canonical WNT signalling) [16] or expression of domin-
ant stable β-catenin [10, 17] all resulted in up-regulated
ovarian WNT signalling and ovarian subfertility caused
by disruption of follicle growth [16, 17], ovulation and
luteinisation [10, 15]. Taken together, these findings indi-
cate the importance of tight regulation of canonical
WNT signalling in growing follicles.
Human ovarian tumours are classified into epithelial
ovarian cancers (90%), sex cord-stromal tumours (7%)
and germ cell tumours (3%). Granulosa cell tumours
(GCTs), which originate from granulosa cells of ovarian
follicles, account for more than half of sex cord-stromal
tumours [18]. WNT signalling mis-regulation has been
implicated in adult GCT formation, as several studies
have demonstrated increased β-catenin protein levels
therein, with nuclear localisation in some cases [17, 19,
20]. A recent molecular study of GCTs showed epigen-
etic silencing of DKK3, the gene coding for the WNT-
signalling antagonist Dickkopf, implying a need for
WNT signalling activation in GCT development (25, 26)
. Furthermore, GEMMs in which WNT signalling was
activated via the introduction of a gain-of-function mu-
tation of R-spondin1 [15], or a degradation-resistant β-
catenin [17], resulted in 15.8% or 57% of mice develop-
ing adult GCTs respectively.
Here, for the first time, we address the importance of
APC2 in ovarian folliculogenesis, fertility and GCT for-
mation. The ability of APC2 to regulate the β-catenin/
WNT signalling pathway has been demonstrated in
Drosophila and in cancer cell lines [21–25]. Structurally,
APC2 possesses AXIN1 and β-catenin binding sites,
which enable it to destabilize β-catenin, targeting it for
degradation and suppressing its transcriptional activity
[22, 26], in addition to the APC-basic domain which en-
ables it to regulate cytoskeleton and microtubule associ-
ation [27–31] and spindle anchoring during mitosis [32].
Importantly, however, in an in vivo setting, APC2-
dependent regulation of WNT signalling is tissue-
specific, occurring in the liver and intestine but not in
the mammary gland [33, 34]. Little is known about how
APC2 functions in adult ovaries, but APC2 loss has been
reported in epithelial ovarian cancer [28, 35]. Here, we
show that Apc2-knockout mice [36] have a subfertility
phenotype associated with an activation of ovarian
WNT signalling, and that, on a hypomorphic Apc back-
ground [37, 38], loss of APC2 increases the incidence of
ovarian GCTs which recapitulate the histologic pattern
and molecular signature of human adult GCTs. Not only
does this study extend our understanding of the tissue-
specific regulation of WNT signalling, but also the
APC2-deficient mouse has excellent potential as a pre-
clinical model to study ovarian tumour biology and for
therapeutic testing.
Methods
Animal models, fertility and ovulation rate
All experiments were carried out under the authority of
UK Home Office personal and project licences and ac-
cording to ARRIVE guidelines and following local ethical
review. Mouse models were maintained on a mixed
C57Bl6/J and 129/Ola background in open cages with ad
libitum access to food and water. Genotyping for the
constitutive knockout allele of Apc2 (Apc2−) and the
hypomorphic allele of Apc (Apcfl) [34, 36–38] were per-
formed as previously described [34, 36] (Additional file
1: Table S1). Typically, experiments compared wild type,
heterozygous Apc2-deleted and homozygous-Apc2 de-
leted mice, with a minimum of three animals per groups,
unless otherwise specified. The breeding defect of Apc2
knockout animals made it difficult, in some cases, to use
large n numbers for analysis; where this is the case it has
been clearly indicated in the text. Animals were eutha-
nased for analysis of ovarian tissue by an approved hu-
mane method (cervical dislocation) at the times
indicated (typically 10 weeks old for functional analysis
and 12 or 18months for tumour studies).
To assess female fertility, retrospective analysis of
breeding performance was analysed from cages in which
two 7–11 week-old female mice of the experimental ge-
notypes (Apc2+/+, Apc2+/− and Apc2−/−) were housed
with a 7–9 week-old male of the same genotype for 3
months (n = 4 cages). Litter sizes were determined at the
time of weaning.
To determine ovulation rates, 10 week-old female mice
were super-ovulated by a single intraperitoneal injection
of 5 IU pregnant mare’s serum gonadotrophin (MSD ani-
mal health, UK), followed by 5 IU human chorionic go-
nadotrophin (MSD animal health, UK), 47 h later [39].
Mice were either euthanased 16–17 (for Cumulus
Oophorus Complex retrieval) [40] or 22–24 h later (for
histological analysis) by an approved humane method
(cervical dislocation).
Cumulus Oophorus complex (COC) retrieval and
characterization
After release from the oviducts, COCs were counted and
examined by bright-field microscopy to assess morph-
ology. Oocytes were freed from surrounding cumulus cells
by addition of 40 μl of 4 mg/ml collagenase/dispase
(Roche, Switzerland), dissolved in DMEM/F12 medium
(Mediatech, USA), for 10min, and examined to determine
their integrity [41] and to measure their diameter [42].
Mohamed et al. BMC Cancer          (2019) 19:677 Page 2 of 16
Histological analysis of ovaries
Follicle counting was performed on ovaries from 10-
week-old Apc2+/+ and Apc2−/− mice, either from ran-
domly cycling females staged manually (using the vaginal
cytology method) and collected at diestrus stage (n = 4)
or 22–24 h post HCG administration (n = 5). Each ovary
was serially-sectioned into 100 5 μM sections and each
10th section was stained with H&E. Growing follicles
were counted every 10th section, when an oocyte nu-
cleus was visible. Identification and classification of
growing follicles and atretic follicles were performed as
previously described [43, 44]. The total number of folli-
cles throughout the 10 counted sections was used. Fol-
licle sizes were measured using a minimum of 4
diameters/follicle.
Hormonal analysis
Serum hormonal levels were measured in 10-week-old
Apc2+/+ and Apc2−/− mice at diestrus stage using ELISA
kits for FSH (Novateinbio, USA) and LH (Enzo Life-
sciences, UK).
Immunohistochemistry
Tissue sectioning and immunohistochemistry were per-
formed as previously described [34], using primary anti-
bodies listed in Additional file 1: Table S2. Sections were
examined with an Olympus BX43 light microscope and
microphotographs taken using a 5 Megapixel HD Micro-
scope Camera (Leica MC170 HD, Germany).
Quantitative RT-PCR analysis
RNA was extracted from whole ovaries or tumour pieces
using RNeasy Plus mini extraction kit (Qiagen,
Germany) and reverse transcription performed using
QuantiTect Reverse transcription kit (Qiagen, Germany).
All quantitative real time rtPCR assays were carried out
three times using TaqMan® universal master mix II with
UNG (Applied Biosystems, USA), Taqman® assays (Add-
itional file 1: Table S3) and QuantStudio™ 7 Flex Real
Time PCR system (ThermoFisher, USA), and relative ex-
pression levels determined using QuantStudio™ 7 Real
Time PCR software.
Statistical analysis
Statistical significance for qRT-PCR data was determined
from 95% confidence intervals [45]. All other statistical
analyses were performed using IBM SPSS version 20
(SPSS Inc., Chicago, IL, USA). Significance testing was
performed using 2-tailed Student’s t-test, when 2 experi-
mental cohorts were compared. When more were com-
pared, ANOVA test was used, followed by a post-hoc
test (LSD or Games-Howell). P-values of < 0.05 were
considered statistically significant.
Results
APC2 deficiency results in sub-fertility
To evaluate the role of APC2 in the biology of the adult
ovary, the impact of APC2 deficiency on normal ovarian
homeostasis and fertility was first assessed. A retrospect-
ive analysis of mating efficiencies of wild type, heterozy-
gous or homozygous breeding trios (Apc2+/+, Apc2+/− or
Apc2−/− respectively) demonstrated that time between
pairing mice and first litter production was significantly
longer in Apc2−/− mice (Fig. 1a). The number of gesta-
tions over the 3-month period following pairing was sig-
nificantly reduced in Apc2−/− mice, with heterozygous
mice also showing a reduction which did not reach sig-
nificance (Fig. 1b). Overall, there was a 40% reduction in
the cumulative number of pups weaned over 3 months
from Apc2+/− trios, compared to Apc2+/+, and this re-
duction was even more pronounced in Apc2−/− mice
(Fig. 1c). Indeed, one Apc2−/− trio was completely infer-
tile over this period.
Histology of ovaries, oviducts and uteri from 10-week-
old virgin Apc2+/+ and Apc2−/− mice revealed no gross
morphological differences in the oviducts and uteri (rep-
resentative images in Additional file 2: Figure S1). No
problems were reported during labour in any of the ex-
perimental groups; it is therefore unlikely that uterine
problems contribute to the observed subfertility pheno-
type. However, there was a significant decrease in the
number of corpora lutea formed in Apc2−/− ovaries (Fig.
1d, e & f), while the total number of growing follicles
was increased, but not significantly (Fig. 1g). Morpho-
metric and histochemical analysis of corpora lutea did
not reveal any histological differences in these structures
between Apc2+/+ and Apc2−/− ovaries (Additional file 3:
Figure S2). Collectively, these findings suggest reduced
ovulation is the cause of the subfertility observed in
APC2-deficient mice.
Subfertility in APC2-deficient female mice is caused by
intra-ovarian defects
Given the constitutive nature of the Apc2 gene deletion
in our mice, the genotype dose-dependent reduction in
fertility, potentially as a result of an ovulation defect,
may be due to defects in extra-ovarian regulation of
ovarian function, triggered by hypothalamic/pituitary
endocrine signals. To address this, follicle stimulating
hormone (FSH) and luteinizing hormones (LH) levels in
serum from 10-week old virgin Apc2+/+ and Apc2−/− fe-
male mice at diestrus stage were analysed by ELISA, but
showed no differences (Additional file 4: Figure S3)a, b,
suggesting hypothalamic/pituitary signals are not af-
fected by Apc2 deletion.
Next, to determine whether the response of the ovary to
endocrine signals was compromised in the context of Apc2
deletion, exogenous gonadotrophins were administered to
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Fig. 1 APC2 loss causes subfertility in adult female mice. a Mating efficiency of Apc2 experimental genotypes as a function of time recorded in
days between pairing the mice and delivering the first litter. N = 4 breeding cages each with one Apc2+/+, Apc2+/− or Apc2−/− male crossed with
2 Apc2+/+, 2 Apc2+/− or 2 Apc2−/− female respectively. One Apc2−/− trio was completely sterile (*P < 0.05). b Breeding efficiency as reflected by
number of gestations occurring in a 3 month period (mean ± S.E, n = 4). c Cumulative number of pups weaned in a 3 month period from 4
breeding pairs. Statistical significance between groups was determined using ANOVA test followed by Games-Howell post hoc analysis (variances
of experimental groups were not homogeneous, tested by Levene’s test). d, e Representative photomicrographs of (d) Apc2+/+ and (e) Apc2−/−
ovaries, showing growing follicles (red arrows) and corpora lutea (black arrows). Bar = 500 μm. f, g Histograms showing total number of (f)
corpora lutea, and (g) healthy growing follicles, counted across 100 serial sections of four ovaries collected from four animals at diestrus stage
(mean ± SE; *P < 0.05, t-test)
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induce superovulation in 10-week-old virgin Apc2+/+,
Apc2+/− and Apc2−/− mice. There was a gene dose-
dependent decrease in the number of cumulus oophorus
complexes (COCs) collected from the ampulla post-
superovulation (Fig. 2a). However, morphological analysis
of the COCs demonstrated that all oocytes were of com-
parable size, surrounded by a layer of cumulus cells of
comparable thickness, and were healthy, with no signs of
fragmentation, irrespective of genotype (Fig. 2b, c).
Importantly, histological analysis post-superovulation
demonstrated a significant reduction in the number of
corpora lutea in super-ovulated Apc2−/− ovaries com-
pared to Apc2+/+ (Fig. 2 d,e&f). As with unstimulated
ovaries, a slight, but non-significant, increase in the
number of healthy growing follicles in Apc2−/− ovaries
was observed (Fig. 2d,e&g). Taken together, these find-
ings suggest that the subfertility phenotype seen in
APC2-deficient female mice is not due to extra-ovarian
defects in pituitary gonadotrophin secretion, but rather
due to intra-ovarian defects in response to gonadotro-
phins that result in reduced ovulation. Therefore, ex-
pression levels of the ovarian gonadotrophin receptors
Fshr and Lhcgr, together with the steroid hormone re-
ceptors Pgr, Esr1, Esr2 and Ar, were assessed in ovaries
from Apc2+/+ and Apc2−/− mice. Significant over-
expression of Lhcgr was evident in Apc2−/− ovaries (Fig.
2h), but the other receptors were unaltered. Importantly,
the LH receptor is a target of canonical WNT signalling
[46], and its over-expression has previously been associ-
ated with infertility in mice [47].
Detailed morphometric analysis, on serial-sectioned
ovaries collected at diestrus stage from Apc2+/+ and
Apc2−/−mice, demonstrated that the trend for an in-
crease in the total number of healthy growing follicles in
Apc2−/− ovaries (Fig. 1g), was restricted to the number
of primary and antral follicles (Fig. 3a). Size distribution
analysis for healthy antral and pre-ovulatory follicles
demonstrated a significant increase in the percentage of
small follicles (diameter < 200 μm) and a significant de-
crease in the percentage of larger follicles (diameter >
300 μm) in Apc2−/− ovaries (Fig. 3b). Analysis of atretic
follicles was undertaken to determine whether increased
atresia was causing the reduction in larger follicles in
Apc2−/− ovaries, but their total number and size distribu-
tion were not significantly altered (Additional file 4: Fig-
ure S3)c,d. IHC for Ki67 revealed that proliferation was
unaltered in follicular granulosa or theca cells (Add-
itional file 4: Figure S3). However, apoptosis, as mea-
sured by cleaved caspase 3 IHC, was significantly
increased in granulosa cells in Apc2−/− follicles (Fig. 3c,
d&e). Histological analysis of pre-ovulatory follicles to-
gether with gene expression analysis of EFG ligands and
receptor did not reveal defects in ovulation (Additional
file 4: Figure S3)f,g. Thus, APC2 deficiency increases
granulosa cell apoptosis, restricting follicular growth and
reducing their ability to reach the pre-ovulatory stage.
APC2 deficiency activates ovarian WNT signalling and
upregulates Foxo1 expression
As APC2 is a known regulator of canonical WNT signal-
ling, we investigated whether dysregulated WNT signal-
ling was mechanistically linked to the restriction in
follicular growth in Apc2−/− ovaries. Ovarian subcellular
localization of β-catenin was assessed by immunohisto-
chemistry (IHC), and expression of a standard panel of
WNT target genes was determined by qRT-PCR, using
whole ovaries collected at diestrus stage from 10-week-
old virgin control (Apc2+/+) and APC2-knockout
(Apc2−/−) mice. IHC analysis of β-catenin revealed a
comparable pattern of expression in all ovarian compart-
ments between control and knockout ovaries (Additional
file 5: Figure S4), although increased staining intensity
was notable in atretic follicles from Apc2−/− ovaries (Fig.
4a). qRT-PCR analysis revealed a significant increase in
the expression levels of Apc, Axin2, Ctnnb1, Fgf1 and
Lgr5 in Apc2−/− ovaries compared to control ovaries
(Fig. 4b). However, there were no significant changes in
Cd44, Lef1 and Wif1.
Given the established role of the FOX family of tran-
scription factors as regulators of apoptosis within ovar-
ian granulosa cells [48–50], and their increased
expression in granulosa cells of cultured follicles post-
WNT signalling activation [51, 52], gene expression
levels for Foxo1, Foxo3 and Foxl2 were analysed in
Apc2+/+ and Apc2−/− whole ovaries. A significant in-
crease in Foxo1 expression levels was seen in Apc2−/−
ovaries (Fig. 4c). Furthermore, the FOXO target genes
Bcl6 and Cdkn1b were significantly upregulated in
Apc2−/− ovaries compared to controls (Fig. 4d).
The PTEN/PI3K/AKT signalling pathway is an estab-
lished regulator of FOXO transcriptional activity and
post-translational modification [53]. On activation of
AKT, FOXO proteins are inactivated by phosphoryl-
ation and translocated from nucleus to cytoplasm [53].
In addition, the crosstalk between activated WNT sig-
nalling and PTEN, causing the over-expression of the
latter, is well established [16, 17, 54]. IHC analysis of
PTEN, p-AKT and p-FOXO1,3,4 in Apc2+/+ and
Apc2−/− ovaries revealed that PTEN expression was
stronger in theca and granulosa cells of Apc2−/− follicles
(Fig. 4e). This was accompanied by a reduction in p-
AKT immunostaining in Apc2−/− granulosa cells (Fig.
4f ) and a consequent reduction in p-FOXO1,3,4 levels
(Fig. 4g). Thus, the increased apoptosis seen in Apc2−/−
follicles is likely due to upregulation of Foxo1 and its
downstream effector genes, secondary to decreased ac-
tivation of PI3K/p-AKT signalling caused by PTEN
upregulation.
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APC2-deficient ovaries show impaired vascularisation and
steroidogenesis
Interaction between β-catenin and FOXO1 has been pre-
viously described to affect tight junctions in endothelial
cells disrupting angiogenesis [55]. Follicular growth im-
pairment has been shown to occur following angiogenesis
disruption, because the vascular network surrounding the
growing follicles is essential for follicular development
[56]. IHC for CD34 was used to compare follicular
vascularization between Apc2+/+ and Apc2−/− ovaries.
While late antral/pre-ovulatory follicles in Apc2+/+ ovaries
were surrounded by 2 continuous layers of endothelial
Fig. 2 (See legend on next page.)
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(See figure on previous page.)
Fig. 2 Exogenous gonadotrophin administration fails to reverse ovarian subfertility of APC2-deficient female mice. a APC2-deficiency caused a
gene dose-dependent decrease in the number of ovulated COCs (mean ± SE) retrieved from the oviducts post-superovulation. b Upper panels,
representative photomicrographs of retrieved COCs showing the presence of oocytes (black arrows) surrounded by cumulus cells (red arrows).
Bar = 200 μm. Lower panels, oocytes freed from cumulus cells. Bar = 50 μm. c Average oocyte diameter (mean ± SE) among experimental groups,
showing no difference. n = 4 for Apc2+/+, n = 3 for Apc2+/−, n = 5 for Apc2−/−. Statistical significance between groups in panels a – c was
determined using ANOVA test followed by LSD post hoc analysis (variances of experiment groups were homogeneous tested by Levene’s test).
d, e Representative photomicrographs of (d) Apc2+/+, and (e) Apc2−/− superovulated ovaries, showing growing follicles (red arrows) and corpora
lutea (black arrows). Bar = 500 μm. f, g Total number of (f) corpora lutea, and (g) healthy follicles counted across 100 serial sections of five
superovulated stage-matched ovaries from different animals (mean ± SE; *P < 0.05, t-test). h Gene expression levels of hormone receptors by qRT-
PCR on RNA extracted from whole ovaries of Apc2+/+ and Apc2−/− 10-week-old female mice. Relative expression levels are normalized to Actb
expression. N = 4 except for lhcgr and Ar in Apc2−/− where n = 3 (mean ± 95% confidence intervals; **P < 0.01, determined from confidence
intervals) [45]
Fig. 3 APC2-deficiency impairs follicular growth in the ovary. a Histogram showing total number of primary (1ry), secondary (2ry), antral and pre-
ovulatory follicles in Apc2+/+ and Apc2−/− ovarian sections (mean ± SE; n = 4; no significant differences, t-test). b Size distribution of healthy antral
and pre-ovulatory follicles (mean ± SE; n = 4; *P < 0.05, t-test). c Histogram showing a > 2-fold increase of apoptosis in granulosa cells of Apc2−/−
follicles (mean ± SE; n = 4; *P < 0.05, t-test). d, e Representative photomicrographs of cleaved caspase 3 immunostaining in (d) Apc2−/− and (e)
Apc2+/+ granulosa cells. Bars = 100 μm
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cells, those in Apc2−/− mice showed discontinuous layers
(Fig. 5a). Furthermore, a significantly reduced level of
Vegfa expression (Fig. 5b) supports the notion of impaired
vascularisation within Apc2−/− ovaries, although it could,
in part, be attributed to the reduced number of corpora
lutea.
Negative regulation of follicle steroidogenesis by ca-
nonical WNT signalling has also previously been dem-
onstrated [52]. We therefore examined the expression of
key enzymes required for steroidogenesis in Apc2 knock-
out ovaries. We found there was significantly reduced
expression of both Cyp17a1 (coding for steroid 17-α-
Fig. 4 Identifying molecular mechanisms associated with subfertility in APC2-deficient ovaries. a Representative photomicrographs of H&E and β-
catenin immunohistochemical staining of atretic follicles showing high expression of β-catenin in granulosa cells of atretic follicles in Apc2−/− vs.
Apc2+/+ ovaries. Bar = 100 μm; insets magnified 2X. b Expression levels of a subset of WNT-target genes compared between Apc2+/+ and Apc2−/−
ovarian extracts by qRT-PCR. Expression levels of five out of eight genes analysed were significantly elevated in Apc2−/− ovaries (mean ± 95%
confidence intervals; n = 4; *P < 0.05, **P < 0.01, determined from confidence intervals) [45]. c, d Relative expression levels of a panel of (c) Fox
transcription factors, and (d) FOX downstream target genes in Apc2+/+ and Apc2−/− 10-week-old ovaries (mean ± 95% confidence intervals; n = 4
for all measurements except for Fasl and Foxo1 in Apc2+/+ where n = 3; *P < 0.05, **P < 0.01, determined from confidence intervals) [45]. e, f, g
Representative photomicrographs of (e) PTEN, (f) p-AKT (ser-473), and (g) p-FOXO1,3,4 immunostaining in Apc2+/+ and Apc2−/− ovarian follicles.
Bars = 200 μm; insets are magnified 2X
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hydroxylase/17,20 lyase) and Cyp19a1 (coding for aro-
matase) in Apc2−/− ovaries compared to Apc2+/+ ovaries
(Fig. 5c).
Therefore, activation of WNT signalling in Apc2 knock-
out ovaries results in overexpression of PTEN and a re-
duction in activity of steroidogenesis and angiogenic
pathways. These metabolic defects combine to result in a
reduced number of follicles maturing to the ovulatory
stage.
Long-term activation of WNT signalling by APC/APC2
deficiency, results in ovarian adult granulosa cell tumour
formation
Because of the WNT signalling-dependent defects ob-
served in 10-week-old Apc2 knockout mice, and the po-
tential role of WNT signalling in driving ovarian tumour
development in mice [15, 17, 54, 57, 58], we aged for up
to 18months cohorts of mice in which WNT signalling
was activated to different levels using a hypomorphic
Apc allele (weak activation of canonical WNT signalling),
hypomorphic Apc plus Apc2+/− knockout (moderate ac-
tivation) or hypomorphic Apc plus Apc2−/− knockout
(strong activation). No gross ovarian tumours were de-
tected in any cohorts at 6 months of age; however 6/29
(20.7%) of the APC2-deficient cohorts (Apc2+/− and
Apc2−/− cohorts on the background of hypomorphic
Apc) had developed adult ovarian GCTs at 12–18
months of age as compared to 1/19 (5.26%) of the
APC2-proficient (hypomorphic Apc only) cohort devel-
oping ovarian GCT at 18months of age (Table 1).
The tumours ranged from small microscopic in situ
tumours to large macroscopic tumours (Fig. 6a-e). Mor-
phologically, they recapitulated human ovarian adult
GCTs and showed a range of different histological pat-
terns (Fig. 6f-l). Cells were highly anaplastic (Fig. 6m)
and mitotic figures were evident (Fig. 6n). Call-Exner
bodies (formed of follicle remnants, Fig. 6j,o) and coffee
bean-shaped nuclei (Fig. 6o), both characteristic of adult
GCTs, were occasionally present.
The molecular signature of the tumours was assessed
by IHC for markers associated with human adult GCTs.
Marker expression patterns in tumours derived from 12
Fig. 5 APC2 loss impairs follicle steroidogenesis and vascularization. a Representative photomicrographs of CD34 immunostaining of follicles in
Apc2+/+ and Apc2−/− 10-week-old ovaries. Bars = 100 μm; insets are magnified 2X. b, c Gene expression levels of (b) Vegfa, and (c) steroidogenic
enzymes by qRT-PCR on ovaries of 10-week-old Apc2+/+ and Apc2−/− female mice (mean ± 95% confidence intervals; n = 4 for all measurements
except for Cyp19a1 in Apc2−/− where n = 3; *P < 0.05, **P < 0.01, determined from confidence intervals) [45]
Table 1 Frequency of GCT formation in 12 and 18-month-old
Apc2 experimental genotypes on the background of Apcfl/fl.
*One animal developed bilateral tumours
Age (months) Genotype Frequency of ovarian GCT
12 Apc2+/+ 0/10 (0%)
12 Apc2+/− 0/4 (0%)
12 Apc2−/− 2*/10 (20%)
18 Apc2+/+ 1/9 (11.1%)
18 Apc2+/− 3/9 (33.3%)
18 Apc2−/− 1/6 (16.67%)
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to 18 month Apc2+/− and Apc2−/− mice were compared
with the single GCT which formed in an 18month
Apc2+/+ animal (all animals also carrying the hypo-
morphic Apc allele, as noted above). In general, the ex-
pression patterns of most of the markers examined was
similar in the Apc2+/+, Apc2+/− and Apc2−/− tumours
(Figs. 7 and 8). Several studies have shown increased
FOXL2 protein expression in human GCTs and animal
models [59–61], and in agreement with these findings,
our GCTs also displayed elevated levels of FOXL2
Fig. 6 Aging APC2-deficient mice develop adult GCTs. Tumours ranged in size from (a) small in situ tumours (arrow) to (b) small tumours of
normal ovarian size, (c, d) small but macroscopically visible tumours or (e) a large macroscopic tumour (arrow). The tumours displayed varying
histologic patterns such as (f) follicular, (g) nodular (arrows), (h) insular, (i) luteinized (arrow: luteinized area shown at 4X original magnification in
inset, L: luteinized, NL: non-luteinized), (j) diffuse (arrow: Call-Exner body), and (k) cystic patterns. The tumours were (l) highly vascularized, (m)
anaplastic, (n) mitotic (black arrow), and showed (o) Call-Exner bodies (black arrow) and coffee-bean nuclei (yellow arrow). Bars a-d = 500 μm, f-
l = 100 μm, m-n = 50 μm, o = 20 μm
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expression (Fig. 7, Additional file 6: Fig. S5)a. The tu-
mours were also positive for inhibin-α, which is used in
the differential diagnosis of GCTs [62], and which
showed focal cytoplasmic staining (Fig. 7). Staining for
Ki67, CD34 and cleaved caspase 3 demonstrated the
classic hallmarks of proliferation, neovascularization
(angiogenesis) and absence of apoptosis respectively, in
all GCTs analysed (Fig. 7). Impaired follicular growth in
10-week-old Apc2−/− ovaries was associated with in-
creased apoptosis (Fig. 3c-e) and Foxo1 expression (Fig.
4c). As apoptosis was reduced in the GCTs from aged
mice, we analysed FOXO1 expression levels by IHC and
observed a reduction in FOXO1 staining in GCT area as
compared to granulosa cells of growing follicles (Fig. 8,
follicle indicated by black arrow; Additional file 6: Figure
S5)b.
To determine whether active canonical WNT signal-
ling was associated with GCT formation, β-catenin stain-
ing was carried out. Tumour cells strongly expressed β-
catenin in contrast to the expression seen in non-
tumour areas (Fig. 8; compare β-catenin staining in
tumour area indicated by black arrow with non-tumour
area indicated by red arrow). Due to limitation of avail-
able tumour samples, qRT-PCR analysis could only be
Fig. 7 Molecular characterization (FOXL2, Inhibin-α, Ki67, CD34, cleaved caspase-3) of GCTs developing in aged (12–18 month) Apc2 deficient
ovaries. Representative photomicrographs of immunohistochemical staining of GCTs developing in Apc2+/+ ovaries (left column) and in Apc2+/−
(middle column) and Apc2−/− (right column) for FOXL2 protein, Inhibin-α, Ki67, CD34 and cleaved caspase-3 (showing absence of apoptosis in
GCT). Note all genotypes also carried an Apc hypomorphic allele. Bar = 500 μm for main panel, 50 μm for insets. To maintain resolution, insets
have been cropped from a representative area of a separate high power photograph, rather than a magnification of the main panel figure
Mohamed et al. BMC Cancer          (2019) 19:677 Page 11 of 16
performed on two WNT signalling target genes (Wif1
and Axin2) using RNA from two Apc2-deficient GCTs,
with Apc2-proficient ovaries used as control material.
Two independent areas from each tumour were analysed
to allow for tumour heterogeneity. Comparison of ex-
pression levels demonstrated higher levels of both Wif1
and Axin2 within APC2-deficient tumours (Additional
file 6: Figure S5)c,d.
Activation of PI3K/AKT signalling via Pten deletion
has been shown to enhance GCT development and
progression in mouse models driven by WNT signalling
activation [63, 64]. However, phospho-AKT (p-AKT), a
marker of active PI3K/AKT signalling, was undetectable
within our GCTs (Fig. 8). Furthermore, Apc2+/− and
Apc2−/− GCTs showed strong PTEN staining, in contrast
to no staining in the Apc2+/+ tumour (Fig. 8). This likely
explains the lack of pAKT staining in the APC2-deficient
tumours. However, the lack of both pAKT and PTEN
staining in the Apc2+/+ tumour may result from the hypo-
morphic APC allele on its own being an insufficiently
Fig. 8 Molecular characterization (FOXO1, β-catenin, p-AKT, PTEN, ERα) of GCTs developing in aged (12–18 month Apc2 deficient ovaries.
Representative photomicrographs of immunohistochemical staining of GCTs developing in Apc2+/+ ovaries (left column) and in Apc2+/− and
Apc2−/− (right column) mice for FOXO1 showing weak staining in GCT, in contrast to a growing follicle (black arrow), β-catenin showing intense
staining in GCT (black arrow) as compared to a corpus luteum (red arrow), p-AKT which was absent in GCT as compared to a growing follicle
(black arrow), PTEN and estrogen receptor alpha (ERα). Note all genotypes also carried an Apc hypomorphic allele. Bar = 500 μm for main panel,
50 μm for insets. To maintain resolution, insets have been cropped from a representative area of a separate high power photograph, rather than
a magnification of the main panel figure
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strong driver of WNT signalling to activate PI3K/AKT sig-
nalling via established cross-talk mechanisms [65].
Estrogen receptor alpha (ERα) also showed differential
staining between APC2-deficient tumours compared to
the APC2-proficient tumour analysed. Human ovarian
GCTs are also characterized by frequent focal staining
for estrogen receptor alpha (ERα) (Fig. 8; Additional file
6: Figure S5)e which suggests that APC2 deficiency not
only increases the frequency of GCTs in mice which also
carry a hypomorphic Apc allele, but also results in tu-
mours with a greater histological and molecular similar-
ity to human GCTs.
Discussion
This study has revealed that APC2-deficiency activates
WNT signalling in the ovary during early adulthood,
which subsequently disrupts ovarian homeostasis and
causes subfertility originating from an ovarian defect.
Follicle growth was perturbed in APC2-deficient mice
secondary to defective response to gonadotrophins, re-
duced follicular vascularity, downregulation of genes
coding for steroidogenic enzymes and upregulation of
Foxo1 expression, which contributed to increased apop-
tosis of granulosa cells in APC2-deficient follicles. At
least 20% of APC2-deficient female mice (on the back-
ground of a hypomorphic Apc allele) go on to develop
WNT-driven GCT as early as 12 months. These tumours
recapitulated human adult GCT histology and molecular
features.
Our findings highlight the role of APC2 as an import-
ant regulator of WNT signalling in the ovary. Although
initial studies performed in Drosophila and on cell lines
to functionally-characterize APC2 demonstrated the
presence of β-catenin and AXIN1 binding sites in APC2,
which enable it to regulate WNT signalling [22, 23, 26,
66–68], in an in vivo mammalian setting, APC2 function
is tissue specific. APC2 loss in the mouse small intestine
and liver resulted in activation of WNT signalling but not
in the mammary glands [33, 34]. Hence, the functions of
APC2 cannot be extrapolated from one mammalian sys-
tem to another without direct experimentation.
The tumour suppressor role of APC2 protein in ovarian
granulosa cell tumour formation has been highlighted
here for the first time and the current study provides fur-
ther evidence of the roles of WNT signalling activation in
the pathogenesis of ovarian GCT. These findings build on
previous work pointing to this role of WNT signalling in
clinical data [17, 19, 20, 69], and in GEMMs [15, 17] but
as noted above, given the tissue-specific effects of APC2
knockout, could not have been predicted a priori.
The current findings also extend our knowledge of dele-
terious effects of WNT signalling activation on ovarian
homeostasis and fertility [10, 15–17]. We have shown that
reduced ovulation observed in APC2-deficient mice is not
caused by defects in ovulation and terminal differentiation
of granulosa cells (which happen when WNT signalling is
activated in antral follicles), but rather caused by restricted
follicular growth and failure to reach the pre-ovulatory
stage. This phenotype is similar to previous phenotypes
published when WNT signalling was activated in pre-
antral follicles [16, 17], implying that APC2 activity is re-
quired in growing follicles as early as the pre-antral stage.
Given the constitutive nature of the Apc2 null allele,
both autonomous and non-autonomous mechanisms are
expected to contribute to the phenotypes described. Re-
sults of the current study have clearly shown the intra-
ovarian origin of the subfertility phenotype described in
APC2-deficient mice, and that hypothalamic-pituitary
regulation of ovarian function is not contributing to the
subfertility phenotype. Although the subfertility is
caused by increased apoptosis of granulosa cells, a con-
tribution of endothelial cells to the phenotype was evi-
dent. Whether the same phenotype could be reproduced
if APC2-deletion was targeted exclusively to granulosa
cells (e.g. using Amhr2 or Cyp19a-cre) remains un-
known, due to the unavailability of an Apc2 conditional
allele. The same applies to GCTs developing in APC2-
deficient mice, which – in contrast – displayed enhanced
angiogenesis.
It is unlikely that WNT signalling activation is the sole
driver of the reported phenotypes and cross talk between
WNT signalling and other signalling pathways must also
be considered. For example, unlike in early adulthood,
FOXO1 expression was absent in APC2-deficient GCT,
implying a need to silence FOXO1 and to stop FOXO1-
driven granulosa cell apoptosis as a prerequisite for
tumourigenesis. It has been previously shown that
knocking out Foxo1/Foxo3 leads to the development of
GCT in 20% of female mice [60]. However, the cause of
the ‘switch’ from FOXO1 being present and granulosa
cell apoptosis to absent FOXO1 with granulosa cell pro-
liferation and tumourigenesis was not identified and
needs to be further characterized. The high levels of
PTEN in granulosa cells of growing follicles might have
contributed to increased apoptosis by inhibiting the
translocation of FOXO1 outside the nucleus and thus
ensuring FOXO1 activates pro-apoptotic target genes. In
addition, high PTEN expression levels found in GCT of
APC2-deficient ovaries might be responsible for the late
development of tumourigenesis, as previously described
in other models [60, 63, 64]. It is thus possible to
hypothesize that, similar to previously published models,
deleting Pten in granulosa cells of APC2-deficient ovar-
ies would lead to rapid tumour development.
This study has caveats. One limitation was that the
breeding data available for different genotypes of female
Apc2 mice (Apc2+/+, Apc2+/−, Apc2−/−) represented
crossings to males of the corresponding genotype, rather
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than to wild type males. Effects of Apc2-gene dosage on
male fertility are not yet characterized, with the caveat
that male fertility might be affected in APC2-deficient
male mice, and could contribute to the delayed preg-
nancy and reduced litter size observed in APC2-
deficient crosses. However, retrieval and counting of
ovulated oocytes post-gonadotrophin administration
confirmed that APC2-deficient female mice ovulate less
and would be expected to give smaller litter size. Impair-
ment of response to gonadotrophin is mediated by over-
expression of Lhcgr, which has been recently reported to
cause complete infertility in female mice, with histo-
logical analysis revealing that follicles failed to progress
beyond the pre-antral stage [47]. Over-expression of
Lhcgr in APC2-deficient mice most likely occurs due to
canonical WNT signalling activation, as a 3.5-fold in-
crease in Lhcgr expression levels has been reported in
granulosa cells transduced with constitutively-active β-
catenin, in the presence of FSH [46]. In addition, this
early elevation of Lhcgr expression might have contrib-
uted to GCT development [46]. Another important cav-
eat to this study was the small numbers of aged Apc2−/−
mice available for tumour development studies. This
was, unfortunately, an unavoidable consequence of the
reduced fertility phenotype in these animals.
Conclusions
This study advances our understanding of the role of
WNT signalling in ovarian homeostasis and tumourigen-
esis, and of the role played by APC2 in regulating this
pathway. The finding that WNT signalling activation in
growing follicles impairs ovulation raises the importance
of the assessment of WNT signalling activation in the
setting of human female subfertility/infertility. This
could provide new insights into the molecular pathogen-
esis of this condition, and may help in designing new
treatment interventions for these patients. Furthermore,
our findings extend the list of mutations which cause fe-
male subfertility or infertility in early adulthood in mice
followed by development of GCT upon aging [15, 17,
47, 60]. It remains to be determined if a similar link ex-
ists in humans and, if so, what are the molecular drivers,
but APC2 must now be included on the list of candi-
dates which should be investigated in this clinical con-
text. Furthermore, the direct mechanistic link between
WNT signalling activation, β-catenin stabilisation and
GCT formation warrants further investigation.
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